Cardiac Arrhythmias, COVID-19
Conditions
Keywords
COVID-19, Cardiac Arrhythmias, Atrial Fibrillation, Telemetry
Brief summary
The objective of the study is to assess the impact of remote cardiac and vital sign monitoring in patients with coronavirus disease (COVID-19) in the outpatient setting.
Detailed description
The objective of the study is to assess the impact of remote cardiac and vital sign monitoring in patients with coronavirus disease (COVID-19) in the outpatient setting. This study will enroll COVID-19 positive patients previously evaluated at Mount Sinai Hospital/Mount Sinai Health System (MSHS) and affiliated hospitals deemed appropriate for home monitoring. Patients will be monitored remotely in the outpatient setting for 1-3 weeks following diagnosis and/or treatment for COVID-19 at MSH/MSHS.
Interventions
DIAGNOSTIC_TESTVitalConnect Vital Sign Patch
This patch provides continuous real-time monitoring of cardiac telemetry, heart rate, respiratory rate and oxygen saturation. Duration of monitoring is typically up to 7 days. This patch is applied to the upper left side of the chest wall, attached with a hypoallergenic adhesive material. (This device is FDA approved for this indication).
Sponsors
Vivek Reddy
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE
Intervention model description
This is a non-randomized study. Based on clinical assessment, patients will be provided with the following home monitoring system: VitalConnect Vital Sign Patch (San Jose, California) This patch provides continuous real-time monitoring of cardiac telemetry, heart rate, respiratory rate and oxygen saturation. Duration of monitoring is typically up to 7 days. This patch is applied to the upper left side of the chest wall, attached with a hypoallergenic adhesive material. (This device is FDA approved for this indication).
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients diagnosed with coronavirus and determined to be eligible for home monitoring and self-care, and either 1. Not admitted to the hospital, and permitted to recover at home 2. Discharged from inpatient hospitalization, during the acute recovery period * 18 years old or older with the ability to understand the requirements of the study and sign the informed consent form (or able to provide over-the-phone verbal consent).
Exclusion criteria
N/A
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of different arrhythmias | 7-14 Days | ac rhythm in patients with COVID-19 infection following treatment/discharge from MSH |
| Temperature | 7-14 Days | Temperature of patients with COVID-19 infection following treatment/discharge from MHS |
| Oxygen Saturation | 7-14 Days | Oxygen saturation level in patients with COVID-19 infection following treatment/discharge from MSH |
Outcome results
None listed